Abstract
This paper was erroneously published under a non-Open Access license. The article is forthwith distributed under the terms of Creative Commons Attribution 4.0 International License. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The article also incorrectly included ‘Clinical Practice Guideline Panel’ in the author line. The original article has been corrected.
| Original language | English |
|---|---|
| Pages (from-to) | 2608 |
| Number of pages | 1 |
| Journal | Diabetologia |
| Volume | 67 |
| Issue number | 11 |
| DOIs |
|
| State | Published - Nov 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Fingerprint
Dive into the research topics of 'Correction to: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary (Diabetologia, (2024), 67, 11, (2375-2392), 10.1007/s00125-024-06196-3)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver